Search
Flickr PhotoStream
Archive for the ‘Drugs’ Category
Which came first, the chicken or the egg? If diuretics had been a panacea for curing hypertension, it is unlikely that drug companies would have taken on the financial risk of developing alternative classes of antihypertensive drugs. As previously discussed, diuretics alone are often inadequate for controlling hypertension and are contraindicated for, or are not [...]
- In: Drugs
- Tags: DIURETIC, DRUG COMPANIES, hypertension, Putting ALLHAT
Metabolic Effects
Chlorthalidone represents one of three different types of diuretics. Each type works in a slightly different way, but all diuretics lower the amount of salt and water in the body, thereby helping to reduce blood pressure. Diuretic treatments are not benign, and not every patient can tolerate them. As a class of drugs, diuretics [...]
- In: Drugs
- Tags: DIURETIC, DRUG COMPANIES, hypertension, Putting ALLHAT
The rest of the second day, conference topics shifted from government perspectives to the effect of the MMA on various private stakeholders. Representatives from pharmaceutical manufacturers, health insurance plans, PBMs, large purchasers of health care, health care providers, and pharmacists talked about how the bill would change their respective practices and the challenges that all [...]
- In: Drugs
- Tags: Drug Congress, Drug Manufacturers, FDA Perspective
The second day of the conference continued with more government perspectives on the effect of the MMA. FDA Commissioner Mark McClellan, newly nominated by President George W. Bush to head the CMS, stated that many senior citizens are considering gambling on the safety and effectiveness of their medications (i.e., buying re-imported medications) because they have [...]
- In: Drugs
- Tags: Drug Congress, Drug Manufacturers, FDA Perspective
Thomas Scully, former CMS administrator, gave several examples “from the battlefield” of the prescription drug legislation and its potential impact on American senior citizens and health care in general. He touted the MMA as “the deal of the century and millennium” and as a “spectacular deal for rich and poor seniors.”
- In: Drugs
- Tags: Drug Congress, Drug Manufacturers, FDA Perspective
The National Medicare Prescription Drug Congress
21, May 2010With a deadline of June 1, 2004, looming for the beginning of the Medicare Prescription Drug Plan (PDP) Discount Card program, a consortium of more than 30 organizations co-sponsored the National Medicare Prescription Drug Congress on Capitol Hill in Washington, DC, from February 25-27, 2004. The main objective was to assess the various areas of [...]
- In: Drugs
- Tags: Drug Congress, Drug Manufacturers, FDA Perspective
Suggestions for Resolving Conflicts in Drug Therapy
16, May 2010PROBLEM: Many serious medication errors that have been reported to the Institute for Safe Medication Practices (ISMP) have involved drug orders that were considered by at least one practitioner to be unsafe. In some cases, the practitioners did not question the orders, because they were reluctant to challenge the prescriber. More often, the practitioners questioned [...]
- In: Drugs
- Tags: Drug Therapy